Stockreport

Arbutus to Receive $116 Million Strategic Investment from Roivant Sciences

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF Cash to Provide Significant Support for Arbutus to Fund HBV R&D PipelineRoivant to Support Accelerating Development of Arbutus’ HBV Pipeline and Maximizing the Value of [Read more]